UK markets close in 4 hours 38 minutes

Marinus Pharmaceuticals, Inc. (MRNS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.3300-0.0200 (-1.48%)
At close: 04:00PM EDT
1.3500 +0.02 (+1.50%)
After hours: 07:36PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-145,344
-141,405
-19,816
-98,776
-67,475
-
Depreciation & amortisation
525
551
418
355
334
-
Stock-based compensation
17,015
15,563
14,890
13,867
7,642
-
Change in working capital
8,730
2,169
-6,092
28,699
-2,042
-
Accounts payable
-
-
-
7,841
1,877
-
Other working capital
-114,103
-118,120
-114,660
-58,366
-60,912
-
Other non-cash items
5,012
5,060
3,331
1,065
626
-
Net cash provided by operating activities
-113,984
-118,001
-112,886
-55,477
-60,912
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-119
-1,774
-2,889
-
-388
Purchases of investments
0
-51,995
0
0
-8,931
-
Sales/maturities of investments
44,385
23,500
107,375
1,474
8,193
-
Net cash used for investing activities
44,275
-28,605
105,772
-1,415
-738
-
Cash flows from financing activities
Debt repayment
0
-
-42
0
-
0
Common stock issued
-
25,823
64,477
0
108,196
-
Other financing activities
-
-
-42
-148
-
-
Net cash used provided by (used for) financing activities
27,058
26,627
124,738
41,310
109,216
-
Net change in cash
-42,651
-119,979
117,624
-15,582
47,566
-
Cash at beginning of period
146,904
240,551
122,927
138,509
90,943
-
Cash at end of period
104,253
120,572
240,551
122,927
138,509
-
Free cash flow
Operating cash flow
-113,984
-118,001
-112,886
-55,477
-60,912
-
Capital expenditure
-
-119
-1,774
-2,889
-
-388
Free cash flow
-114,103
-118,120
-114,660
-58,366
-60,912
-